Has This Teen Been Physically Abused?

Article

Benzodiazepines and opioids; visual hallucinations; solid food dysphagia . . . can you answer this week’s quiz questions?

Question 1:

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

Question 2:

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among reproductive-aged women.

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

 

Question 3:

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

 

Question 4:

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

Question 5:

A 76-year-old man was referred for evaluation of chronic intermittent dysphagia for solid food. He had a history of rectal cancer that was diagnosed 8 years earlier. Endosonographic ultrasonography showed a thickened gastric wall of the cardia. Endoscopic mucosal resection was performed. Pathology results are shown.

ANSWER KEY »


For the discussion, click here.


 

ANSWER KEY:

Question 1. B

Question 2. D

Question 3. G

Question 4. B

Question 5. C

Recent Videos
Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
Related Content
Vertex on the Verge of Breakthrough for Nonopioid Pain Management as NOPAIN Act Takes Effect

Vertex on the Verge of Breakthrough for Nonopioid Pain Management as NOPAIN Act Takes Effect

Grace Halsey
January 13th 2025
Article

Suzetrigine, the investigational selective NaV1.8 pain signal inhibitor, with a PDUFA date of Jan 30, could become a first-in-class nonopioid analgesic.

Obesity & Pain Management: A Primary Viewpoints Podcast

Obesity & Pain Management: A Primary Viewpoints Podcast

Sydney Jennings
April 27th 2023
Podcast

In our latest episode, an obesity medicine physician explains the importance of a comprehensive plan to manage chronic pain in patients with obesity.

Vertex Nonopioid Analgesic on Par with Placebo in Phase 2 Study of Lumbosacral Radiculopathy / image credit ©decade3D/stock.adobe.com

Vertex Nonopioid Analgesic on Par with Placebo in Phase 2 Study of Lumbosacral Radiculopathy

Grace Halsey
December 19th 2024
Article

Pain relief with suzetrigine was comparable to that seen with placebo, an issue Vertex plans to address with study design as the drug moves to the pivotal phase 3 trials.

Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management

Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management

Sydney Jennings
September 29th 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Lynn Webster, MD, past president of the American Academy of Pain Medicine.

Suzetrigine Phase 3 Data Presented During "Best Abstract" Session at Anesthesiologists' Annual Meeting / image credit postop concept: ©Justlight AI/stock.adobe.com

Vertex Presents Phase 3 Data on Nonopioid Suzetrigine to Treat Acute Pain at Anesthesiologists' Annual Meeting

Grace Halsey
October 21st 2024
Article

The FDA has set a PDUFA date of January 30, 2025 for the investigational oral nonopioid therapy for acute pain, which could be a first-in-class win for Vertex.

Depression, Anxiety in Youth with Chronic Pain: Daily Dose / image credit: ©New Africa/AdobeStock

Depression, Anxiety in Youth with Chronic Pain: Daily Dose

Sydney Jennings
October 15th 2024
Article

Your daily dose of the clinical news you may have missed.

© 2025 MJH Life Sciences

All rights reserved.